Combined Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine-Related Erythema Nodosum: Case Report and Review of Vaccine-Associated Erythema Nodosum
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology
Link
http://link.springer.com/content/pdf/10.1007/s13555-013-0035-9
Reference24 articles.
1. McCormack PL. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix): a review of its properties and use as a single-dose immunization. Drugs. 2012;72:1765–91.
2. Plosker GL. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10–64 years in the US. BioDrugs. 2009;23:253–67.
3. Clark TA, Bobo N. CDC update on pertussis surveillance and Tdap vaccine recommendations. NASN Sch Nurse. 2012;27:297–300.
4. Centers for Disease Control and Prevention. American Academy of Pediatrics Committee on Infectious Diseases: additional recommendations for use of tetanus toxoid, reduced-content diphtheria toxoid, and acellular pertussis vaccine (Tdap). Pediatrics. 2011;128:809–12.
5. Chang S, O’Connor PM, Slade BA, Woo EJ. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005–2007. Vaccine. 2013;31:1447–52.
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Erythema Nodosum in an Infant Associated With Meningococcal ACWY, Measles, Mumps, Rubella, and Pneumococcal Vaccines: A Case Report;Clinical Pediatrics;2023-11-06
2. Delayed Recurrent Erythema Nodosum Following COVID-19 Vaccine: A Case Report;Cureus;2023-07-31
3. Erythema Nodosum;Dermatology in Public Health Environments;2023
4. Erythema nodosum after COVID ‐19 vaccine: Report of two pediatric cases;Pediatric Dermatology;2022-11-30
5. Erythema nodosum after COVID-19 vaccination in a pediatric patient;JAAD Case Reports;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3